🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Specific Antibody Deficiency

EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors NCT06525298Phase 1, Phase 21 site📍 Houston Eisbach Bio GmbH · Tests: EIS-12656, Olaparib, Trastuzumab deruxtecan A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs). NCT04319367Phase 212 sites📍 Aarhus📍 Brighton📍 Edinburgh Imperial College London · Tests: Investigational Medicinal Product Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease NCT06605378n/a52 sites📍 Montgomery📍 Phoenix📍 Little Rock Ensoma Frequency of SPAD in Adult Patients NCT05664035n/a1 site📍 Lille University Hospital, Lille · Tests: Diagnosis of SPAD using immunization with PPV23 Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART Control NCT05300035Phase 217 sites📍 Bobigny📍 Clamart📍 Clichy ANRS, Emerging Infectious Diseases · Tests: Recombinant human monoclonal antibody (bNAbs), Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy